GlassScriptPhysician profile
Asaf Klein
NPI 1669761631
$24,530.89
in general payments reported to CMS, 2019-2025
42 companies · $2,070 in 2025
The $2,070 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,192 · 2020: $3,462 · 2021: $3,619 · 2022: $4,260 · 2023: $4,021 · 2024: $2,907 · 2025: $2,070.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,919 · Education: $77.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,919.33 |
| Education | $77.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $4,447.15 | 2019-2025 | Evenity, Tavneos, Prolia |
| Abbvie INC. | $3,178.16 | 2019-2025 | |
| Janssen Biotech, INC. | $2,938.98 | 2019-2025 | Tremfya, Simponi Aria, Simponi |
| Lilly USA, LLC | $1,740.09 | 2019-2024 | Taltz, Zepbound, Olumiant |
| Novartis Pharmaceuticals Corporation | $1,641.21 | 2019-2025 | |
| Glaxosmithkline, LLC. | $1,553.95 | 2019-2025 | Benlysta |
| Pfizer INC. | $1,546.48 | 2019-2025 | |
| Ucb, INC. | $1,437.59 | 2019-2024 | Cimzia |
| Astrazeneca Pharmaceuticals LP | $743.89 | 2021-2025 | Saphnelo |
| E.R. Squibb & Sons, L.L.C. | $664.53 | 2019-2023 | Orencia |
| Radius Health, INC. | $595.28 | 2019-2025 | Tymlos |
| Mallinckrodt Hospital Products INC. | $528.70 | 2020-2025 | Acthar |
| Aurinia Pharma U.S., INC. | $462.39 | 2021-2025 | Lupkynis |
| Genentech USA, INC. | $420.93 | 2019-2024 | Actemra |
| Bioventus LLC | $344.52 | 2019-2025 | Gelsyn-3 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asaf Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.